| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| GTO ID | GTC2308 |
| Trial ID | NCT04271644 |
| Disease | Multiple Myeloma | Plasma Cell Neoplasm |
| Altered gene | BCMA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | BCMA CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | BCMA-Targeted CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma |
| Year | 2019 |
| Country | China |
| Company sponsor | Chongqing Precision Biotech Co., Ltd |
| Other ID(s) | PBC002 |
| Cohort 1 | |||||||
|
|||||||